Serena Williams has been taking a GLP-1 medication to help with her recent weight loss, she revealed for the first time in an ...

Serena Williams recently detailed her weight loss journey, sharing that she lost 31 pounds with the assistance of a GLP-1 ...

With 23 Grand Slam singles titles and four Olympic gold medals, Serena Williams is undeniably a superathlete. But the 43-year ...

Originally appeared on E! Online Serena Williams is serving up an honest look into her weight ...

Yet the tennis legend knows firsthand how harshly people judge the use of GLP-1 drugs for weight loss. Now, she’s using her ...

As someone who had built her career on grit and hard work, Williams hesitated before exploring weight-loss medications ...

For reasons that remain unclear, kidney cancer risk was higher in users of GLP-1 agonists, particularly those under 65 and those who were overweight versus obese.< Patients taking GLP-1 agonists for ...

She changed her diet and maintained a strict workout regimen. But since there were no results, Williams turned to GLP-1 ...

It is through this company that she gets prescribed Zepbound, a GLP-1 medication. Williams admitted to initially being ...

GLP-1 receptor agonists may outperform metformin in lowering the risk for dementia, particularly Alzheimer’s disease and other nonvascular types, in patients with type 2 diabetes.

GLP-1 receptor agonists may reduce cancer risk among people with obesity or overweight, according to retrospective study results.Adults who used GLP-1 medications exhibited a statistically significant ...